Precigen Inc. buy krebskrebs
Start price
08.08.22
/
50%
€2.05
Target price
08.08.23
€3.00
Performance (%)
-46.34%
End price
09.08.23
€1.10
Summary
This prediction ended on 09.08.23 with a price of €1.10. Massive losses of -46.34% were the result for the BUY prediction by krebskrebs. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Precigen Inc. | -8.254% | -8.254% | 40.678% |
iShares Core DAX® | -0.870% | -1.700% | 10.560% |
iShares Nasdaq 100 | -5.561% | -3.604% | 34.335% |
iShares Nikkei 225® | -6.138% | -7.732% | 16.215% |
iShares S&P 500 | -3.141% | -2.011% | 24.534% |
Comments by krebskrebs for this prediction
In the thread Meridian Energy Ltd diskutieren
Buy mit Kursziel 3,0
In the thread Trading Precigen Inc.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten